Related Experiment Video

Updated: Jun 13, 2026

Long-term Monitoring of Oxygen Consumption Rates in Highly Differentiated and Polarized Retinal Pigment Epithelial Cultures
08:09

Long-term Monitoring of Oxygen Consumption Rates in Highly Differentiated and Polarized Retinal Pigment Epithelial Cultures

Published on: August 16, 2024

Altered mTOR signaling in senescent retinal pigment epithelium

Yan Chen1, Jian Wang, Jiyang Cai

  • 1Vanderbilt Eye Institute, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA. yan.chen@vanderbilt.edu

Investigative Ophthalmology & Visual Science
|May 7, 2010
PubMed
Abstract

Insights

The mammalian target of rapamycin (mTOR) pathway influences aging. Inhibiting mTORC1 in human retinal pigment epithelial (RPE) cells can delay RPE aging and senescence.

Area of Science:

  • Cellular biology
  • Aging research
  • Ophthalmology

Background:

  • The mammalian target of rapamycin (mTOR) pathway is crucial for regulating cellular processes, including aging.
  • Understanding mTOR's role in retinal pigment epithelial (RPE) cells is vital for age-related eye conditions.

Purpose of the Study:

  • To characterize the mTOR signaling cascade in human RPE cells.
  • To investigate the role of mTOR in controlling RPE senescence.

Main Methods:

  • Western blot analysis to assess mTOR component expression.
  • Coimmunoprecipitation to determine mTORC1 and mTORC2 complex formation.
  • Measurement of senescence markers (SA-β-Gal activity, p16 expression) and mTORC1 activity (S6 phosphorylation).

Main Results:

  • Human RPE cells possess functional mTORC1 and mTORC2 signaling complexes.
  • mTORC1 activity is responsive to nutrient and growth factor signals, with increased sensitivity in senescent RPE cells.
  • Rapamycin-induced suppression of mTORC1 prevented senescence markers in RPE cells.

Conclusions:

  • The mTOR pathway exhibits age-associated alterations in human RPE cells.
  • Downregulating mTORC1 activity can potentially delay the aging process in RPE cells.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...